About Pharma Industry

BNET Pharma provides daily industry trends and news coverage with insights for managers and executives about major manufacturers of pharmaceuticals and medicine. In addition to detailed drug company profiles, we bring you industry analysis on new partnerships, drug patents and products, cost management, investments, pharmaceutical related lawsuits, and a host of other important business issues.

As Lilly, Pfizer Lobby Against Obama Healthcare Plan, Their Execs Enjoy Gold-Plated Coverage

By Jim Edwards | Jul 10, 2009

Eli Lilly, Pfizer, and PhRMA all oppose a pubic heathcare plan, according to the Center for Responsive Politics. Instead, they’d like to see individual insurance mandates and an expansion of health savings accounts. But their top executives have health insurance plans which include cash payments of thousands of dollars and coverage that extends for years if they get laid off.

For most us, when we lose a job we lose our healthcare coverage pretty quickly after that. Sure, we’re offered Cobra coverage but unless you need long-term or catastrophic care, it’s often cheaper just to pay cash. Top execs at Lilly and Pfizer, however, don’t worry about any of this. If they get laid off their coverage continues for another two years.

At Lilly:

Basic employee benefits such as health and life insurance would be continued for up to two years following termination of employment. All executives, including named executive officers, are entitled to two years’ benefit continuation. This period will be reduced to 18 months beginning in 2010.

At Pfizer:

… eligible executives would receive a pro-rata target annual incentive for the year of termination as well as certain health and welfare benefits.

CFO Frank D’Amelio has a special deal just for him:

… for the two-year period following termination of employment (or, if earlier, until he becomes eligible to receive group health coverage from another employer), he will continue to receive group health benefits from Pfizer at our expense.

The other execs — CEO Jeff Kindler et al — do not currently meet the requirement for coverage so the company will award them between $108,000 and $142,000 each in lieu of benefits.

PhRMA, to its credit, is arguing for an extension of Medicaid.

What, exactly, Lilly wants to see in President Obama’s plan is a little confusing. The company’s new top  mouthpiece, Bart Peterson, told the Indianapolis Business Journal that Lilly doesn’t want to take “today’s” coverage and “make it available to everybody”:

The most important part of the message is the importance of preserving innovation. A lot of the health care debate has been about, how do we cover the uninsured, how do we reduce the costs of health care? These are very important issues, obviously.

But we don’t want to just take today’s health care system, today’s level of care, and make it available to everybody. We want it to get better and better.

That could mean anything. The one thing it definitely does not mean is, “We support a plan in which employers continue healthcare coverage for years after we lay off employees, and if employees don’t qualify we’ll pay them the cash value instead.”

Image: healthcare reform-haters Harry and Louise.

Disclosure: The author has no healthcare coverage and would like some.

Jim Edwards, a former managing editor of Adweek, has covered drug marketing at Brandweek for four years, and is a former Knight-Bagehot fellow at Columbia University's business and journalism schools. Follow him on Twitter or send him an email.

BNET User Analysis

Web Buzz:
  • Pharma invests $28.8M in Q2 lobbying$

    FiercePharma - 203 days 9 hours 39 minutes ago

    Drugmakers continue to pour dollars into Washington coffers as the debate over healthcare reform shows no sign of stopping. New numbers from lobbying reports filed yesterday show that PhRMA ploughed $6.2 million into lobbying during the second quarter. Pfizer spent more than any other individual drugmaker at $5.6 million. As the Washington Post...

  • Pharma shells out $1.2M daily on lobbying$

    FiercePharma - 218 days 9 hours 31 minutes ago

    With healthcare reform topping lawmakers' to-do lists, politics is high up on Big Pharma's priorities. And drugmakers are not only putting money where their mouths are, but are hiring some consummate insiders to do the talking. The Center for Responsive Politics has crunched the numbers and found that the pharma industry is spending $1.2 million...

  • Pollack Explains Health Coalition: 'If The Ultimate Question Is Where Did I Hammer Karen Ignagni, That's Not What Happened'

    Wonk Room - 315 days 6 hours 17 minutes ago

    Six months ago, a diverse group of stakeholders -- Families USA, NFIB, Business Roundable, America's Health Insurance Plans, PhRMA, among others -- began holding a series of Health Reform Dialogues to, as they put it, "create a forum outside of the political arena for exchanging views on tough policy issues." Last week, the group released a...

  • The Best Congress Lobbying Can Buy

    Mother Jones - 15 days 3 hours 6 minutes ago

    K Street's federal lobbying reports were due last week, and OpenSecrets is back with some initial numbers. The U.S. Chamber of Commerce spent the most on lobbying federal lawmakers, increasing its spending by 58% from 2008 as it stepped up efforts to defeat climate change and health care legislation. $79.2 million—more than half of its...

  • AZ Chief appointed head of PhRMA

    FierceBiotech - 307 days 10 hours 9 minutes ago

    AstraZeneca Chief Executive Officer David Brennan  has been elected board chairman of the Pharmaceutical Research and Manufacturers of America (PhRMA). Pfizer has appointed Martin Mackay  as president, PharmaTherapeutics Research Group, and Mikael Dolsten as president, BioTherapeutics Research Group. Emilio Emini will join Pfizer as...

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
Click Here